Literature DB >> 3029225

The immunoglobulin heavy chain switch: structural features of gamma 1 recombinant switch regions.

J Petrini, B Shell, M Hummel, W Dunnick.   

Abstract

The immunoglobulin heavy chain isotype switch is mediated by a DNA rearrangement involving specific genomic segments referred to as switch regions. Switch regions are composed of tandemly repeated simple sequences. The role of the tandemly repeated structure of switch regions in the switch recombination process is not understood. We mapped eight recombination sites--six in the gamma 1 and two in the gamma 3 tandem arrays. In addition, we obtained molecular clones representing three of the six gamma 1 rearrangements, and determined the nucleotide sequences of the recombination sites in each. In general, the rearrangements are confined to the tandem repeat units, and are not clustered in a particular portion of either the gamma 3 or gamma 1 switch region. Nucleotide sequence analysis of one of the recombinant clones, gamma M35, reveals evidence for a successive switch event wherein a recombination between S mu and S gamma 3 was followed by recombination 57 bp downstream with S gamma 1. gamma 1 sequence data from the molecular clones we obtained, together with similar data from other investigators regarding the gamma 1, gamma 2b, and gamma 2a switch regions, reveals that recombinations tend to occur at homologous positions of the respective gamma-unit repeats, adjacent to the elements AGCT and GGGG found in each. This finding suggests that the cutting and religation step of the recombination process is mediated by a recombinase common to the four gamma-isotypes.

Mesh:

Substances:

Year:  1987        PMID: 3029225

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Detection of an immunoglobulin switch region-specific DNA-binding protein in mitogen-stimulated mouse splenic B cells.

Authors:  R A Wuerffel; A T Nathan; A L Kenter
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

2.  A rearrangement of the CDD gene at the 5' UTR produces two types of transcripts that contain a natural antisense region.

Authors:  H Jung-Ha; Y Lee; D Kim; B H Song
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

3.  Analysis of immunoglobulin Sgamma3 recombination breakpoints by PCR: implications for the mechanism of isotype switching.

Authors:  J Du; Y Zhu; A Shanmugam; A L Kenter
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1.

Authors:  L A Hanakahi; L A Dempsey; M J Li; N Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Mutations, duplication, and deletion of recombined switch regions suggest a role for DNA replication in the immunoglobulin heavy-chain switch.

Authors:  W Dunnick; M Wilson; J Stavnezer
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

Review 6.  DNA sequences at immunoglobulin switch region recombination sites.

Authors:  W Dunnick; G Z Hertz; L Scappino; C Gritzmacher
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

7.  Gamma heavy chain disease in man. Genomic sequence reveals two noncontiguous deletions in a single gene.

Authors:  A Alexander; I Anicito; J Buxbaum
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

8.  Directed Ig class switch recombination in activated murine B cells.

Authors:  E Winter; U Krawinkel; A Radbruch
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

9.  Rearrangement between ornithine decarboxylase and the switch region of the gamma 1 immunoglobulin gene in alpha-difluoromethylornithine resistant mouse myeloma cells.

Authors:  A Katz; C Kahana
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

10.  Heavy-chain class switch does not terminate somatic mutation.

Authors:  H Shan; M Shlomchik; M Weigert
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.